Author:
Ihara Fumie,Sakurai Daiju,Takami Mariko,Kamata Toshiko,Kunii Naoki,Yamasaki Kazuki,Iinuma Tomohisa,Nakayama Toshinori,Motohashi Shinichiro,Okamoto Yoshitaka
Funder
Ministry of Education, Culture, Sports, Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference38 articles.
1. Vicari AP, Zlotnik A (1996) Mouse NK1.1+ T cells: a new family of T cells. Immunol Today 17:71–76
2. Taniguchi M, Koseki H, Tokuhisa T, Masuda K, Sato H, Kondo E, Kawano T, Cui J, Perkes A, Koyasu S, Makino Y (1996) Essential requirement of an invariant Vα 14 T cell antigen receptor expression in the development of natural killer T cells. Proc Natl Acad Sci USA 93:11025–11028
3. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M (1997) CD1d-restricted and TCR-mediated activation of Vα 14 NKT cells by glycosylceramides. Science 278:1626–1629
4. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S, Iizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M (1999) Antitumor cytotoxicity mediated by ligand-activated human Vα 24 NKT cells. Cancer Res 59:5102–5105
5. Motohashi S, Nakayama T (2008) Clinical applications of natural killer T cell-based immunotherapy for cancer. Cancer Sci 99:638–645
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献